ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Accounts Payable
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Accounts Payable of -$593.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.14M, a 43.37% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$119.00K, a 171.26% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.61M.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.49M, a 141.07% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for fiscal 2025 was -$5.38M, a 201.38% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for fiscal 2024 was $5.30M, a 967.40% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for fiscal 2023 was $497.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts payable for fiscal 2022 was -$914.00K, a 221.70% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | $1.02M derived: sum of 2 quarters · filed 2026-08-28 | -$593.00K 10-Q · filed 2026-08-28 | -$3.08M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | -$1.73M 10-Q · filed 2026-08-28 | -$4.22M derived: sum of 3 quarters · filed 2026-08-28 | -$2.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$1.61M 10-Q · filed 2026-02-09 | -$4.10M derived: sum of 2 quarters · filed 2026-08-28 | -$2.10M derived: sum of 3 quarters · filed 2026-08-28 | -$1.93M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | -$2.49M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$485.00K derived: sum of 2 quarters · filed 2026-08-28 | -$318.00K derived: sum of 3 quarters · filed 2026-08-28 | -$5.38M 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | $2.17M derived: sum of 2 quarters · filed 2026-08-28 | -$2.89M 10-Q · filed 2026-08-28 | $3.18M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | -$4.89M 10-Q · filed 2026-08-28 | $1.17M derived: sum of 3 quarters · filed 2026-08-28 | $1.01M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | -$5.06M 10-Q · filed 2026-02-09 | $1.00M derived: sum of 2 quarters · filed 2026-08-28 | $841.00K derived: sum of 3 quarters · filed 2026-08-28 | $275.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | $6.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $5.90M derived: sum of 2 quarters · filed 2026-08-28 | $5.33M derived: sum of 3 quarters · filed 2026-08-28 | $5.30M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | -$164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$730.00K derived: sum of 2 quarters · filed 2025-08-12 | -$760.00K 10-Q · filed 2025-08-12 | -$590.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | -$566.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | -$596.00K 10-Q · filed 2025-05-13 | -$426.00K derived: sum of 3 quarters · filed 2026-08-28 | -$2.56M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | -$30.00K 10-Q · filed 2025-02-12 | $140.00K derived: sum of 2 quarters · filed 2026-08-28 | -$1.99M derived: sum of 3 quarters · filed 2026-08-28 | -$996.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $170.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$1.96M derived: sum of 2 quarters · filed 2026-08-28 | -$966.00K derived: sum of 3 quarters · filed 2026-08-28 | $497.00K 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-06 | -$1.14M derived: sum of 2 quarters · filed 2024-08-06 | $327.00K 10-Q · filed 2024-08-06 | $328.07K 10-Q · filed 2023-08-08 | $1.03M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $993.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $2.46M 10-Q · filed 2024-05-09 | $2.46M 10-Q · filed 2023-05-09 | $3.15M derived: sum of 3 quarters · filed 2024-05-09 | $3.65M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $1.46M 10-Q · filed 2024-02-07 | $1.46M 10-Q · filed 2023-02-07 | $2.16M derived: sum of 2 quarters · filed 2024-02-07 | $2.66M derived: sum of 3 quarters · filed 2024-02-07 | $653.99K derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | $698.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.19M derived: sum of 2 quarters · filed 2023-11-27 | -$809.01K derived: sum of 3 quarters · filed 2023-11-27 | -$914.00K 10-K · filed 2023-11-27 | -$915.00K 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | -$1.51M derived: sum of 2 quarters · filed 2023-08-08 | -$1.61M 10-Q · filed 2023-08-08 | -$1.05M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | -$2.11M 10-Q · filed 2023-05-09 | -$1.54M derived: sum of 3 quarters · filed 2023-11-27 | -$1.03M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | -$104.99K 10-Q · filed 2023-02-07 | $458.36K derived: sum of 2 quarters · filed 2023-11-27 | $977.01K derived: sum of 3 quarters · filed 2023-11-27 | $418.11K derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | $563.35K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.08M derived: sum of 2 quarters · filed 2023-11-27 | $523.11K derived: sum of 3 quarters · filed 2023-11-27 | $751.00K 10-K · filed 2023-11-27 | $750.73K 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $518.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-09 | -$40.24K derived: sum of 2 quarters · filed 2022-08-09 | $187.65K 10-Q · filed 2022-08-09 | $196.50K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | -$558.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | -$331.00K 10-Q · filed 2022-05-10 | -$322.15K derived: sum of 3 quarters · filed 2022-11-28 | $8.32K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | $227.89K 10-Q · filed 2022-02-09 | $236.74K derived: sum of 2 quarters · filed 2022-11-28 | $567.21K derived: sum of 3 quarters · filed 2022-11-28 | $297.78K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | $8.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $339.32K derived: sum of 2 quarters · filed 2022-11-28 | $69.89K derived: sum of 3 quarters · filed 2022-11-28 | $465.72K 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | $330.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $61.04K derived: sum of 2 quarters · filed 2021-08-12 | $456.87K 10-Q · filed 2021-08-12 | $873.61K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$269.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $126.40K 10-Q · filed 2021-05-13 | $543.14K derived: sum of 3 quarters · filed 2021-05-13 | -$1.62M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $395.83K 10-Q · filed 2021-02-16 | -$395.83K 10-Q · filed 2020-02-06 | $812.57K derived: sum of 2 quarters · filed 2021-02-16 | -$1.36M derived: sum of 3 quarters · filed 2021-02-16 | -$3.90K derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | $416.74K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | -$1.75M derived: sum of 2 quarters · filed 2020-12-28 | -$399.73K derived: sum of 3 quarters · filed 2020-12-28 | $683.80K 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | -$816.47K derived: sum of 2 quarters · filed 2020-08-06 | $267.06K 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $2.43M 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | $1.08M 10-Q · filed 2020-02-06 | |||||||
| 2018-09-30 | $38.23K 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |